Robust Sampling of Defective Pathways in Multiple Myeloma
Open Access
- 21 September 2019
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (19), 4681
- https://doi.org/10.3390/ijms20194681
Abstract
We present the analysis of defective pathways in multiple myeloma (MM) using two recently developed sampling algorithms of the biological pathways: The Fisher’s ratio sampler, and the holdout sampler. We performed the retrospective analyses of different gene expression datasets concerning different aspects of the disease, such as the existing difference between bone marrow stromal cells in MM and healthy controls (HC), the gene expression profiling of CD34+ cells in MM and HC, the difference between hyperdiploid and non-hyperdiploid myelomas, and the prediction of the chromosome 13 deletion, to provide a deeper insight into the molecular mechanisms involved in the disease. Our analysis has shown the importance of different altered pathways related to glycosylation, infectious disease, immune system response, different aspects of metabolism, DNA repair, protein recycling and regulation of the transcription of genes involved in the differentiation of myeloid cells. The main difference in genetic pathways between hyperdiploid and non-hyperdiploid myelomas are related to infectious disease, immune system response and protein recycling. Our work provides new insights on the genetic pathways involved in this complex disease and proposes novel targets for future therapies.This publication has 22 references indexed in Scilit:
- Design of Biomedical Robots for Phenotype Prediction ProblemsJournal of Computational Biology, 2016
- Genetics of multiple myeloma: another heterogeneity level?Blood, 2015
- Supervised Classification by Filter Methods and Recursive Feature Elimination Predicts Risk of Radiotherapy-Related Fatigue in Patients with Prostate CancerCancer Informatics, 2014
- Multiple myeloma–related deregulation of bone marrow–derived CD34+ hematopoietic stem and progenitor cellsBlood, 2012
- Vitamin D deficiency in a man with multiple myeloma2011
- Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cellsMolecular Cancer, 2010
- Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6Blood, 2010
- The molecular characterization and clinical management of multiple myeloma in the post-genome eraLeukemia, 2009
- Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression ProfilingCancer Research, 2007
- Molecular Pathogenesis and a Consequent Classification of Multiple MyelomaJournal of Clinical Oncology, 2005